WSC 2026 | New frontiers in ICH: blood pressure control and secondary prevention
Aristeidis Katsanos, MD, PhD, McMaster University, Hamilton, Canada, discusses recent developments in the management of intracerebral hemorrhage (ICH), including the importance of blood pressure control and the potential role of polypill and antihypertensive injectables in achieving better secondary stroke prevention. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
Yeah, the important thing is blood pressure control. So we need to make sure that we have a tight control of the blood pressure in our ICH patients. The reality is that most of our patients, they don’t reach their target. And even if they reach the target, they’re not adhering over a long time. For secondary stroke prevention, polypill is going to be very important in achieving that target...
Yeah, the important thing is blood pressure control. So we need to make sure that we have a tight control of the blood pressure in our ICH patients. The reality is that most of our patients, they don’t reach their target. And even if they reach the target, they’re not adhering over a long time. For secondary stroke prevention, polypill is going to be very important in achieving that target. We have also some injectables, some antihypertensive injectable formats that are currently being tested in trials, and hopefully we’re going to have them for secondary stroke prevention, including after ICH, you know, to see if they’re going to work and if they’re going to bring the blood pressure down and decrease the risk of hemorrhage.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
